Emily E. Scott

4.7k total citations
86 papers, 3.9k citations indexed

About

Emily E. Scott is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Emily E. Scott has authored 86 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pharmacology, 31 papers in Molecular Biology and 20 papers in Oncology. Recurrent topics in Emily E. Scott's work include Pharmacogenetics and Drug Metabolism (64 papers), Computational Drug Discovery Methods (18 papers) and Drug Transport and Resistance Mechanisms (17 papers). Emily E. Scott is often cited by papers focused on Pharmacogenetics and Drug Metabolism (64 papers), Computational Drug Discovery Methods (18 papers) and Drug Transport and Resistance Mechanisms (17 papers). Emily E. Scott collaborates with scholars based in United States, United Kingdom and China. Emily E. Scott's co-authors include Natasha M. DeVore, James R. Halpert, Quentin Gibson, John S. Olson, Patrick Porubsky, Eric F. Johnson, Mark A. White, You Ai He, Grażyna D. Szklarz and Kathleen M. Meneely and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Emily E. Scott

83 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily E. Scott United States 34 2.1k 1.7k 760 759 626 86 3.9k
Dijana Matak‐Vinković United Kingdom 24 976 0.5× 1.9k 1.1× 556 0.7× 488 0.6× 329 0.5× 41 3.2k
C.D. Stout United States 26 1.4k 0.7× 1.6k 1.0× 645 0.8× 614 0.8× 124 0.2× 49 3.5k
Julian A. Peterson United States 37 3.3k 1.6× 3.2k 1.9× 1.1k 1.4× 759 1.0× 533 0.9× 84 6.0k
Irina F. Sevrioukova United States 33 1.6k 0.7× 1.8k 1.1× 569 0.7× 566 0.7× 164 0.3× 74 3.4k
Keith J. Griffin United States 34 2.6k 1.2× 2.6k 1.6× 1.3k 1.7× 871 1.1× 113 0.2× 46 5.6k
Moshe Finel Finland 45 1.9k 0.9× 3.5k 2.1× 1.0k 1.3× 140 0.2× 308 0.5× 156 6.0k
Sergey A. Usanov Belarus 24 1.0k 0.5× 1.0k 0.6× 316 0.4× 269 0.4× 186 0.3× 137 2.6k
Ronald E. White United States 28 1.5k 0.7× 1.5k 0.9× 668 0.9× 296 0.4× 282 0.5× 70 3.8k
Jason K. Yano United States 20 1.9k 0.9× 1.6k 1.0× 1.0k 1.3× 1.1k 1.4× 70 0.1× 29 3.6k
Ken Korzekwa United States 27 2.2k 1.1× 937 0.6× 1.6k 2.0× 461 0.6× 88 0.1× 67 3.4k

Countries citing papers authored by Emily E. Scott

Since Specialization
Citations

This map shows the geographic impact of Emily E. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily E. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily E. Scott more than expected).

Fields of papers citing papers by Emily E. Scott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily E. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily E. Scott. The network helps show where Emily E. Scott may publish in the future.

Co-authorship network of co-authors of Emily E. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Emily E. Scott. A scholar is included among the top collaborators of Emily E. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily E. Scott. Emily E. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Estrada, D. Fernando, et al.. (2024). Tracking protein–protein interactions by NMR: conformational selection in human steroidogenic cytochrome P450 CYP17A1 induced by cytochrome b 5. Physical Chemistry Chemical Physics. 26(24). 16980–16988. 1 indexed citations
2.
Liu, Jinghan, et al.. (2023). Pyridine-containing substrate analogs are restricted from accessing the human cytochrome P450 8B1 active site by tryptophan 281. Journal of Biological Chemistry. 299(4). 103032–103032. 3 indexed citations
3.
Roberts, Arthur G., Jeffrey Stevens, Grażyna D. Szklarz, et al.. (2022). Four Decades of Cytochrome P450 2B Research: From Protein Adducts to Protein Structures and Beyond. Drug Metabolism and Disposition. 51(1). 111–122. 3 indexed citations
4.
Morais, Goreti Ribeiro, et al.. (2021). Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents. Drug Metabolism and Disposition. 50(1). 49–57. 9 indexed citations
5.
Gillam, Elizabeth M. J., et al.. (2020). Structure of an ancestral mammalian family 1B1 cytochrome P450 with increased thermostability. Journal of Biological Chemistry. 295(17). 5640–5653. 22 indexed citations
6.
Wróbel, Tomasz M., Kasper Langebjerg Andersen, Rahul Yadav, et al.. (2020). Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents. International Journal of Molecular Sciences. 21(14). 4868–4868. 8 indexed citations
7.
Scott, Emily E., Dawson J. Kidgell, Ashlyn K. Frazer, & Alan J. Pearce. (2020). The Neurophysiological Responses of Concussive Impacts: A Systematic Review and Meta-Analysis of Transcranial Magnetic Stimulation Studies. Frontiers in Human Neuroscience. 14. 306–306. 16 indexed citations
8.
Yadav, Rahul, Elyse M. Petrunak, D. Fernando Estrada, & Emily E. Scott. (2016). Structural insights into the function of steroidogenic cytochrome P450 17A1. Molecular and Cellular Endocrinology. 441. 68–75. 28 indexed citations
9.
Petrunak, Elyse M., Natasha M. DeVore, Patrick Porubsky, & Emily E. Scott. (2014). Structures of Human Steroidogenic Cytochrome P450 17A1 with Substrates. Journal of Biological Chemistry. 289(47). 32952–32964. 103 indexed citations
10.
Reed, Timothy M., Gerald H. Lushington, Hidehiko Hirakawa, et al.. (2010). Crystal Structure of Histamine Dehydrogenase from Nocardioides simplex. Journal of Biological Chemistry. 285(33). 25782–25791. 18 indexed citations
11.
Porubsky, Patrick, K.P. Battaile, & Emily E. Scott. (2010). Human Cytochrome P450 2E1 Structures with Fatty Acid Analogs Reveal a Previously Unobserved Binding Mode. Journal of Biological Chemistry. 285(29). 22282–22290. 79 indexed citations
12.
DeVore, Natasha M., et al.. (2009). Key Residues Controlling Binding of Diverse Ligands to Human Cytochrome P450 2A Enzymes. Drug Metabolism and Disposition. 37(6). 1319–1327. 37 indexed citations
13.
Scott, Emily E., Steven S. Perakis, & David E. Hibbs. (2008). δ15N Patterns of Douglas-Fir and Red Alder Riparian Forests in the Oregon Coast Range. Forest Science. 54(2). 140–147. 18 indexed citations
14.
Porubsky, Patrick, Emily E. Scott, & Todd D. Williams. (2008). p-Dimethylaminocinnamaldehyde derivatization for colorimetric detection and HPLC–UV/vis–MS/MS identification of indoles. Archives of Biochemistry and Biophysics. 475(1). 14–17. 6 indexed citations
15.
Reed, Timothy M., Hidehiko Hirakawa, Minae Mure, Emily E. Scott, & Julian Limburg. (2008). Expression, purification, crystallization and preliminary X-ray studies of histamine dehydrogenase fromNocardioides simplex. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 64(9). 785–787. 1 indexed citations
16.
Li, Weihua, Hong Liu, Emily E. Scott, et al.. (2005). POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION. Drug Metabolism and Disposition. 33(7). 910–919. 47 indexed citations
17.
Kumar, Santosh, Emily E. Scott, Hong Liu, & James R. Halpert. (2003). A Rational Approach to Re-engineer Cytochrome P450 2B1 Regioselectivity Based on the Crystal Structure of Cytochrome P450 2C5. Journal of Biological Chemistry. 278(19). 17178–17184. 47 indexed citations
18.
Millar, David J., et al.. (1993). Production and characterisation of monoclonal antibodies to the principle sonicate antigens ofPorphyromonas gingivalisw50. FEMS Immunology & Medical Microbiology. 7(3). 211–222. 15 indexed citations
19.
Wilton, James, et al.. (1993). Inhibition of polymorphonuclear leucocyte phagocytosis by Porphyromonas gingivalis culture products in patients with adult periodontitis. Archives of Oral Biology. 38(4). 285–289. 16 indexed citations
20.
Scott, Emily E., et al.. (1988). Quantitation of autoantibodies to cytokeratins in sera from patients with squamous cell carcinoma of the oesophagus. British Journal of Cancer. 58(6). 767–772. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dijana Matak‐Vinković Breakdown of academic impact, for papers by C.D. Stout Breakdown of academic impact, for papers by Julian A. Peterson Breakdown of academic impact, for papers by Irina F. Sevrioukova Breakdown of academic impact, for papers by Keith J. Griffin Breakdown of academic impact, for papers by Moshe Finel Breakdown of academic impact, for papers by Sergey A. Usanov Breakdown of academic impact, for papers by Ronald E. White Breakdown of academic impact, for papers by Jason K. Yano Breakdown of academic impact, for papers by Ken Korzekwa
Rankless by CCL
2026